Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal (scientific article published on 20 August 2013)

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin

Q30415832

Anal squamous cell carcinoma in the HIV-positive patient

Q37427853

Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study

Q37710115

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial

Q43973278

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index

Q44323781

Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).

Q46587294

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

chemoradiotherapy

Q5090613

P1104

number of pages

P304

page(s)

3769-3775

P577

publication date

2013-08-20

P1433

published in

Cancer

Q326041

P1476

title

Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

P478

volume

119

Reverse relations

cites work (P2860)

Q34465769	Anal cancer treatment: current status and future perspectives
Q98164822	Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center
Q35530203	Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities.
Q89612279	Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy
Q38627519	Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study
Q33763918	One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity.
Q38225033	Optimal management of squamous cell carcinoma of the anal canal: where are we now?
Q38227802	Optimal treatment strategies for anal cancer
Q38647761	Pharmacotherapy of Anal Cancer
Q37573426	Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis
Q52642515	Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

P356	DOI	10.1002/CNCR.28296
P698	PubMed publication ID	24037775